Neurizon’s fast-track application for flagship drug in Europe received ‘positively’
While the final decision is set for next month, biotech player Neurizon’s…
Neurizon Therapeutics Limited (ASX:NUZ)
About Neurizon Therapeutics Limited
Key Information
NUZ In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 19/11/2024 | Updated Securities Trading Policy | 564.32KB | 528 |
| 15/11/2024 | Correction to text positioning error in announcement | 977.1KB | 1.4K |
| 15/11/2024 | Price Sensitive PS Neurizon Presents Positive Preclinical Data on NUZ-001 | 4.26MB | 3.4K |
| 15/11/2024 | Price Sensitive PS NUZ-001 Reduces Aggregation of Key ALS Disease Target | 679.45KB | 27K |
| 11/11/2024 | Price Sensitive PS Positive opinion received on OMPD for NUZ-001 in Europe | 327.54KB | 12K |
| 08/11/2024 | Change of Director's Interest Notices x4 | 748.49KB | 843 |
| 07/11/2024 | Notification regarding unquoted securities - NUZ | 20.35KB | 12K |
| 07/11/2024 | Notification regarding unquoted securities - NUZ | 21.63KB | 817 |